References
- Escobar-Morreale, H.F. (2018). Polycystic ovary syndrome: definition, aetiology, diagnosis and treatment. Nat Rev Endocrinol. 14(5): 270-284. https://doi.org/10.1038/nrendo.2018.24 PMid:29569621
- Witchel, S.F., Oberfield, S.E., Peña, A.S. (2019). Polycystic ovary syndrome: pathophysiology, presentation, and treatment with emphasis on adolescent girls [presentation]. J Endocr Soc. 3(8): 1545-1573. https://doi.org/10.1210/js.2019-00078 PMid:31384717 PMCid:PMC6676075
- Sanchez-Garrido, M.A., Tena-Sempere, M. (2020). Metabolic dysfunction in polycystic ovary syndrome: pathogenic role of androgen excess and potential therapeutic strategies. Mol Metab. 35, 100937. https://doi.org/10.1016/j.molmet.2020.01.001 PMid:32244180 PMCid:PMC7115104
- Palomba, S., Daolio, J., La Sala, G.B. (2017). Oocyte competence in women with polycystic ovar y syndrome. Trends Endocrinol Metab. 28(3): 186-198. https://doi.org/10.1016/j.tem.2016.11.008 PMid:27988256
- Dadachanji, R., Shaikh, N., Mukherjee, S. (2018). Genetic variants associated with hyperandrogenemia in PCOS pathophysiology. Genet Res Int. 2018, 7624932. https://doi.org/10.1155/2018/7624932 PMid:29670770 PMCid:PMC5835258
- Xu, X.L., Deng, S.L., Lian, Z.X., Yu, K. (2021). Estrogen receptors in polycystic ovary syndrome. Cells. 10(2): 459. https://doi.org/10.3390/cells10020459 PMid:33669960 PMCid:PMC7924872
- González, F., Nair, K.S., Daniels, J.K., Basal, E., Schimke, J.M., Blair, H.E. (2012). Hyperandrogenism sensitizes leukocytes to hyperglycemia to promote oxidative stress in lean reproductive-age women. J Clin Endocrinol Metab. 97(8): 2836-2843. https://doi.org/10.1210/jc.2012-1259 PMid:22569241 PMCid:PMC3410256
- Rudnicka, E., Duszewska, A.M., Kucharski, M., Tyczyński, P., Smolarczyk, R. (2022). Oxidative stress and reproductive function: oxidative stress in polycystic ovary syndrome. Reproduction. 164(6): F145-F154. https://doi.org/10.1530/REP-22-0152 PMid:36279177
- Jensterle, M., Kravos, N.A., Ferjan, S., Goricar, K., Dolzan, V., Janez, A. (2020). Long-term efficacy of metformin in overweight-obese PCOS: longitudinal follow-up of retrospective cohort. Endocr Connect. 9(1): 44-54. https://doi.org/10.1530/EC-19-0449 PMid:31829964 PMCid:PMC6993269
- Alesi, S., Forslund, M., Melin, J., Romualdi, D., Peña, A., Tay, C.T., Witchel, S.F., et al. (2023). Efficacy and safety of anti-androgens in the management of polycystic ovary syndrome: a systematic review and meta-analysis of randomised controlled trials. EClinicalMedicine. 63, 102162. https://doi.org/10.1016/j.eclinm.2023.102162 PMid:37583655 PMCid:PMC10424142
- Forslund, M., Melin, J., Alesi, S., Piltonen, T., Romualdi, D., Tay, C.T., Witchel, S., et al. (2023). Different kinds of oral contraceptive pills in polycystic ovary syndrome: a systematic review and meta-analysis. Eur J Endocrinol. 189(1): S1-S16. https://doi.org/10.1093/ejendo/lvad082 PMid:37440702
- Lanzo, E., Monge, M., Trent, M. (2015). Diagnosis and management of polycystic ovary syndrome in adolescent girls. Pediatr Ann. 44(9): e223-230. https://doi.org/10.3928/00904481-20150910-10 PMid:26431241 PMCid:PMC5659205
- Rathee, P., Rathee, S. (2022). A review of polycystic ovarian syndrome in Ayurveda. IRJAY 05(2): 114-117. https://doi.org/10.47223/IRJAY.2022.5220
- Lakshmi, J.N., Babu, A.N., Kiran, S.S.M., Nori, L.P., Hassan, N., Ashames, A. Bhandare, R.R., Shaik, A.B. (2023). Herbs as a source for the treatment of polycystic ovarian syndrome: A systematic review. BioTech (Basel). 12(1): 4. https://doi.org/10.3390/biotech12010004 PMid:36648830 PMCid:PMC9844343
- Alok, S., Jain, S.K., Verma, A., Kumar, M., Mahor, A., Sabharwal, M. (2013). Plant profile, phytochemistry and pharmacology of Asparagus racemosus (Shatavari): a review. Asian Pac J Trop Dis. 3(3): 242-251. https://doi.org/10.1016/S2222-1808(13)60049-3
- Tandon, V.R. (2005). Medicinal uses and biological activities of Vitex negundo. Nat Prod Rad. 4(3): 162-165.
- Pandey, A.K., Gupta, A., Tiwari, M., Prasad, S., Pandey, A.N., Yadav, P.K., et al. (2018). Impact of stress on female reproductive health disorders: possible beneficial effects of shatavari (Asparagus racemosus). Biomed Pharmacother. 103, 46-49. https://doi.org/10.1016/j.biopha.2018.04.003 PMid:29635127
- Bano, U., Jabeen, A., Ahmed, A., Siddiqui, M.A. (2015). Therapeutic uses of Vitex nigundo. World J Pharm Med. 4(12): 589-606.
- Jajra, S.D., Panwar, N., Adlakha, M.K., Purvia, R.P., Gautam, V., Singh, C. (2019). Role of (Vitex negundo) nirgundi in pain management. World J Pharm Med. 8(7): 2083-2089.
- Siriwardene, S.D., Kar unathilaka, L.A., Kodituwakku, N.D., Karunarathne, Y.A. (2010). Clinical efficacy of Ayurveda treatment regimen on Subfertility with poly cystic ovarian syndrome (PCOS). AYU 31(1): 24-27. https://doi.org/10.4103/0974-8520.68203 PMid:22131680 PMCid:PMC3215317
- Kakadia, N., Patel, P., Deshpande, S., Shah, G. (2018). Effect of Vitex negundo L. seeds in letrozole induced polycystic ovarian syndrome. J Tradit Complement Med. 9(4): 336-345. https://doi.org/10.1016/j.jtcme.2018.03.001 PMid:31453130 PMCid:PMC6701941
- Singh, R. (2016). Asparagus racemosus: a review on its phytochemical and therapeutic potential. Nat Prod Res. 30(17): 1896-1908. https://doi.org/10.1080/14786419.2015.1092148 PMid:26463825
- Soren, A.D., Yadav, A.K. (2021). Studies on the anthelmintic potentials of the roots of Asparagus racemosus willed. Clin Phytosci. 7, 32. https://doi.org/10.1186/s40816-021-00270-8
- Kafali, H., Iriadam, M., Ozardalı, I., Demir, N. (2004). Letrozole-induced polycystic ovaries in the rat: a new model for cystic ovarian disease. Arch Med Res. 35(2): 103-108. https://doi.org/10.1016/j.arcmed.2003.10.005 PMid:15010188
- Balasubramanian, A., Pachiappan, S., Mohan, S., Adhikesavan, H., Karuppasamy, I., Ramalingam, K. (2023). Therapeutic exploration of polyherbal formulation against letrozole induced PCOS rats: a mechanistic approach. Heliyon. 9(5): e15488. https://doi.org/10.1016/j.heliyon.2023.e15488 PMid:37180914 PMCid:PMC10173408
- Weydert, C.J., Cullen, J.J. (2010). Measurement of superoxide dismutase, catalase and glutathione peroxidase in cultured cells and tissue. Nat Protoc. 5(1): 51-66. https://doi.org/10.1038/nprot.2009.197 PMid:20057381 PMCid:PMC2830880
- Rosenfield, R.L., Ehr mann, D.A. (2016). The pathogenesis of polycystic ovar y syndrome (PCOS): the hypothesis of PCOS as functional ovarian hyperandrogenism revisited. Endocr Rev. 37(5): 467-520. https://doi.org/10.1210/er.2015-1104 PMid:27459230 PMCid:PMC5045492
- Gervásio, C.G., Bernuci, M.P., Silva-de-Sá, M.F., Rosa-e-Silva, A.C. (2014). The role of androgen hormones in early follicular development. ISRN Obstet Gynecol. 2014, 818010. https://doi.org/10.1155/2014/818010 PMid:25006485 PMCid:PMC4003798
- Chauvin, S., Cohen-Tannoudji, J., Guigon, C.J. (2022). Estradiol signaling at the heart of folliculogenesis: its potential deregulation in human ovarian pathologies. Int J Mol Sci. 23(1): 512. https://doi.org/10.3390/ijms23010512 PMid:35008938 PMCid:PMC8745567
- Bries, A.E., Webb, J.L., Vogel, B., Carrillo, C., Keating, A.F., Pritchard, S.K., Roslan, G., et al. (2021). Letrozole-induced polycystic ovar y syndrome attenuates cystathionine-β synthase mRNA and protein abundance in the ovaries of female Sprague Dawley rats. J Nutr. 151(6): 1407-1415. https://doi.org/10.1093/jn/nxab038 PMid:33758914 PMCid:PMC8169814
- Mandalà, M. (2020). Inf luence of estrogens on uterine vascular adaptation in normal and preeclamptic pregnancies. Int J Mol Sci. 21(7): 2592. https://doi.org/10.3390/ijms21072592 PMid:32276444 PMCid:PMC7177259
- Kuiper, G.G., Lemmen, J.G., Carlsson, B.O., Corton, J.C., Safe, S.H., Van Der Saag, P.T., van der Burg, B., Gustafsson, J.A. (1998). Interaction of estrogenic chemicals and phytoestrogens with estrogen receptor β. Endocrinology. 139(10): 4252-4263. https://doi.org/10.1210/endo.139.10.6216 PMid:9751507
- Sabnis, P.B., Gaitonde, B.B., Jetmalani M. (1968). Effects of alcoholic extracts of Asparagus racemosus on mammary glands of rats. Indian J Exp Biol. 6(1): 55-57.
- Payne, A.H., Hales, D.B. (2004). Overview of steroidogenic enzymes in the pathway from cholesterol to active steroid hormones. Endocr Rev. 25(6): 947-970. https://doi.org/10.1210/er.2003-0030 PMid:15583024
- Sun, Y., Zhang, J., Ping, Z., Fan, L., Wang, C., Li, W., Lu, C., Zheng, L., Zhou, X. (2011). Expression of 3β-hydroxysteroid dehydrogenase (3β-HSD) in normal and cystic follicles in sows. Afr J Biotechnol. 10(32): 6184-6189.
- Hu, J., Zhang, Z., Shen, W.J., Azhar, S. (2010). Cellular cholesterol deliver y, intracellular processing and utilization for biosynthesis of steroid hormones. Nutr Metab (Lond). 7, 47. https://doi.org/10.1186/1743-7075-7-47 PMid:20515451 PMCid:PMC2890697
- Bednarska, S., Siejka, A. (2017). The pathogenesis and treatment of polycystic ovary syndrome: what’s new? Adv Clin Exp Med. 26(2): 359-367. https://doi.org/10.17219/acem/59380 PMid:28791858
- Dumesic, D.A., Akopians, A.L., Madrigal, V.K., Ramirez, E., Margolis, D.J., Sarma, M.K., Thomas, A.M., et al. (2016). Hyperandrogenism accompanies increased intra-abdominal fat storage in normal weight polycystic ovary syndrome women. J Clin Endocrinol Metab. 101(11): 4178-4188. https://doi.org/10.1210/jc.2016-2586 PMid:27571186 PMCid:PMC5095243
- Zhang, Y., Liu, L., Yin, T.L., Yang, J., Xiong, C.L. (2017). Follicular metabolic changes and effects on oocyte quality in polycystic ovary syndrome patients. Oncotarget. 8(46): 80472-80480. https://doi.org/10.18632/oncotarget.19058 PMid:29113318 PMCid:PMC5655213
- Zuo, T., Zhu, M., Xu, W. (2016). Roles of oxidative stress in polycystic ovary syndrome and cancers. Oxid Med Cell Longev. 2016, 8589318. https://doi.org/10.1155/2016/8589318 PMid:26770659 PMCid:PMC4684888
- Younas, A., Hussain, L., Shabbir, A., Asif, M., Hussain, M., Manzoor, F. (2022). Effects of Fagonia indica on letrozole-induced polycystic ovarian syndrome (PCOS) in young adult female rats. Evid Based Complement Alternat Med. 2022, 1397060. https://doi.org/10.1155/2022/1397060 PMid:35664938 PMCid:PMC9162856